Sleep Apnea Linked to Increased Liver Disease Risk

Researchers found a strong connection between sleep-disordered breathing and metabolic liver issues in patients.

Updated on Sept. 30, 2026 in Sleep Disorders

Bold vector editorial illustration showing stylized anatomical lung and liver forms with flowing lines, representing the connection between sleep breathing and liver health.
A 2026 meta-analysis found a significant link between sleep apnea and metabolic dysfunction-associated steatotic liver disease, prompting clinicians to screen patients. AI Illustration. Upload story photo >

Live Poll

Should patients with chronic sleep apnea undergo routine screening for liver health?

A 2026 meta-analysis identified a significant association between sleep-disordered breathing and metabolic dysfunction-associated steatotic liver disease (MASLD). The study indicates that the presence of sleep apnea may be a contributing factor in the development of liver health complications.

Why it matters

Identifying this link suggests that sleep-disordered breathing may impact the progression of metabolic liver disease. Consequently, clinicians are now encouraged to consider regular liver health assessments for patients already diagnosed with sleep apnea.

A systematic review and meta-analysis of 8 studies found that sleep-disordered breathing is associated with MASLD at an odds ratio of 3.62. While CPAP treatment led to reduced liver enzymes, randomized data on structural liver improvement remains limited.

The details

Sleep-disordered breathing often causes nocturnal hypoxemia, or periods of low oxygen in the blood, which appears more strongly linked to liver damage than the apnea-hypopnea index. While continuous positive airway pressure (CPAP) therapy was associated with mean reductions in liver enzymes like alanine aminotransferase by 7.15 U/L, it did not significantly improve markers of fibrosis or liver structure in controlled analyses.

Timeline

  1. The systematic review and meta-analysis was published in 2026.

Health Landscape

This study integrates the treatment of sleep disorders into the broader metabolic health landscape, shifting focus toward multisystem management. It highlights that addressing respiratory health is a critical, often overlooked component in managing chronic metabolic liver disease.

If you have been diagnosed with sleep apnea, it is worth discussing the potential impact on your metabolic health with your doctor. Regular liver health screenings may be beneficial for those struggling with sleep-disordered breathing to catch signs of liver damage early.

The takeaway

This research reinforces the importance of viewing sleep health as a pillar of metabolic function. Patients with sleep apnea should ask their physician about the necessity of liver enzyme blood tests to monitor for signs of steatosis or fibrosis.

Further reading

For more information on the latest clinical guidelines, visit our Sleep Disorders section.

More information

Review the full findings in the systematic review and meta-analysis published in 2026.

Source note: This article includes information reported by Ajmc.

Live Poll

Should patients with chronic sleep apnea undergo routine screening for liver health?